Bluebird Lenti-D Data Give Gene Therapy Business Another Boost
Results Show Continued Positive Safety, Efficacy Profile
The news comes less than a week after data partially exonerated its other gene therapy in a cancer scare announced in February.
The news comes less than a week after data partially exonerated its other gene therapy in a cancer scare announced in February.